Employer Drug Coverage Will Shift To Part D, Stakeholders Say
This article was originally published in The Pink Sheet Daily
Executive Summary
Companies will accept the government subsidy for retirees’ drug coverage initially, but will move former workers to the Medicare drug benefit in later years, executives from Kaiser Foundation Health Plans and the Employers Coalition on Medicare predict.
You may also be interested in...
Most Employers’ Retiree Rx Coverage Will Continue After Medicare Part D – Survey
Kaiser Family Foundation/Hewitt survey finds 58% of large employers plan to accept the government subsidy to continue offering retiree drug benefits that are actuarially equivalent to Part D. Only 8% expect to discontinue retiree Rx coverage.
Most Employers’ Retiree Rx Coverage Will Continue After Medicare Part D – Survey
Kaiser Family Foundation/Hewitt survey finds 58% of large employers plan to accept the government subsidy to continue offering retiree drug benefits that are actuarially equivalent to Part D. Only 8% expect to discontinue retiree Rx coverage.
Broad Medicare Formularies Would Negatively Impact Rx Industry, PCMA Says
Limiting PBMs’ ability to control costs in Medicare Rx would benefit advocates of a government-run health care system, Pharmaceutical Care Management Association CEO Merritt says. Broad drug formularies also would increase costs for employers, he says.